Tyrphostins that suppress the growth of human papilloma virus 16- immortalized human keratinocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1442-1457

  Ben Bassat, H ^a,b   Rosenbaum Mitrani, S ^b   Hartzstark, Z ^a   Levitzki, R ^a   Chaouat, M ^a   Shlomai, Z ^a   Klein, B Y ^a   Kleinberger Doron, N ^c   Gazit, A ^c   Tsvieli, R ^b   Levitzki, A ^c  

^a Laboratory of Experimental Surgery   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AG 1387; AG 18; AG 494; AG 555; AG 814; AG 974; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DIARYL KETONE; GROWTH INHIBITOR; KETOL; TRANSFERASE INHIBITOR; TYRPHOSTIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL IMMORTALIZATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MITOSIS INHIBITION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; KERATINOCYTES; PAPILLOMAVIRIDAE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYRPHOSTINS;

EID: 0032812928     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ben-Bassat H, Eldad A, Chaouat M, Livoff A, Ron N, Neeman Z and Wexler MR (1992) Structural and functional evaluation of modifications in the composite plain graft; cryopreserved dermis and cultured keratinocytes. Plast Reconstr Surg 89: 510-520.
2. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Shlomai Z, Kleinberger-Doron N, Gazit A, Plowman R, Levitzki R, Tsvieli R and Levitzki A (1997) Inhibitors of the EGF receptor and of Cdk2 activation induce growth arrest, differentiation, and apoptosis of HPV16 immortalized human keratinocytes. Cancer Res 57:3741-3750.
3. Ben-Bassat H, Vardi DV, Gazit A, Klaus SN, Chaouat M, Hartzstark Z and Levitzki A (1995) Tyrphostins suppress the growth of psoriatic keratinocytes. Exp Dermatol 4:82-88.
4. Bilder G, Krawiec JA, Gazit, A, Gilon C, McVety K, Lyall R, Zilberstein A, Levitzki A, Perrone M and Schreiber AB (1991) Tyrphostins inhibit PDGF induced DNA synthesis, tyrosine specific protein kinase activity and c-fos mRNA expression in vascular smooth muscle cells. Am J Physiol 260:C721-C730.
5. Braly P (1996) Preventing cervical cancer. Nat Med 2:749-751.
6. Burger AM, Kaur G, Alley M, Supko JG, Malspeis L, Grever MR and Sausville EA (1995) Tyrphostin AG17, [(3,5-di-tert-butyl-4-hydroxybenzylidene)-malononitrile], inhibits cell growth by disrupting mitochondria. Cancer Res 55:2794-2799.
7. Dyson N and Howley PM (1989) The HPV 16 E7 oncoprotein is able to bind the Rb gene product Science (Wash DC) 243:934-937.
8. Fry DW, Kracker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW and Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Wash DC) 215:1093-1095.
9. Gazit A, App H, McMahon G, Chen J, Levitzki A and Bohmer FD (1996a) Tyrphostin 5. Potent inhibitors of PDGF receptor tyrosine kinase: SAR in quinixalines, quinolines and indole tyrphostins. J Med Chem 39:2170-2177.
10. Gazit A, Chen J, App H, McMahon G, Hirth P, Chen I and Levitzki A (1996b) Tyrphostin 4. Highly potent inhibitors of EGF receptor kinase: Structure activity relationship study of 4-anilido quinazolines. Biorg Med Chem 8:1203-1207.
11. Gazit A, Osherov N, Gilon C and Levitzki A (1996c) Tyrphostin 6. Dimeric benzylidene malono nitriles tyrphostins: Potent inhibitors of EGF receptor tyrosine kinase in vitro. J Med Chem 39:4905-4911.
12. Gazit A, Osherov N, Posner I, Bar-Sinai A, Gilon C, and Levitzki A (1994) Benzylidenemalononitrile tyrphostins. J Med Chem 36:3556-3564.
13. Gazit, A, Osherov N, Posner I, Yaish E, Poradosu C and Levitzki A (1991) Tyrphostins II: Heterocydic and a-substituted benzonemaloronitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem 84:1897-1907.
14. Gazit A, Yaish P, Gilon C and Levitzki A (1989) Tyrphostins I: Synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32:2344-2352.
15. Goldman R and Bar-Shavit Z (1979) Dual effect of normal stimulated macrophages and their conditioned media on target cell proliferation. Cancer Inst 63:1004-1016.
16. Golomb G, Fishbein I, Banai S, Mishaly D, Moscowitz D, Gertz A, Gazit A and Levitzki A (1996) Controlled delivery of a tyrphostin inhibits initial hyperplasia in rat carotid artery injury model. Atherosclerosis 125:171-182.
17. Greenhalgh DA, Wang KJ, Donehower LA and Roop DR (1996) Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos or human transformic growth factor α. Cancer Res 56:4413-4423.
18. Howley PM (1991) Role of the human papilloma viruses in human cancers. Cancer Res 51:5019s-5022s.
19. 1 and S phase. Exp Cell Res 241:340-351.
20. Lang HH, Mungal S, Ayscue A, Weissner JD, Wodmicki P, Hockenbery D, Lockett S and Herman B (1995) Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J Cell Biochem 57:509-521.
21. Malejczyk J, Malejczyk M, Majewski S, Breitburd F, Luger TA, Jablonska S and Orth G (1994) Increased tumorigenicity of human keratinocytes harboring HPV16 is associated with resistance to endogenous TNFα mediated growth inhibition. Int J Cancer 56:593-598.
22. Mitrani-Rosenbaum S and Tsvieli R (1992) Differential cooperation of a carcinogen with human papilloma virus type 6 & 16 DNAs in vitro oncogenic transformation. Intervirology 33:76-85.
23. Nigro JM, Aldape KD, Hess SW and Testy TD (1997) Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res 57:3635-3639.
24. Osherov N and Levitzki A (1997) Tyrphostin AG 494 blocks Cdk2 activation. FEBS Lett 410:187-190.
25. Palumbo A, Yaron N, Gazit A, Sandalon Z, Baniyash H, Kleinberger-Doron N, Levitzki A and Ben-Yehuda D (1997) The tyrphostin AG 17 induces apoptosis and inhibition of Cdk-2 activity in lymphoma cell line that overexpresses bcl-2. Cancer Res 57:2434-2439.
26. Parker SH, Tong T, Bolden S and Winko PA (1996) Cancer statistics. Cancer J Clin 46:5-27.
27. Pecoraro G, Worgan D and Defendi V (1989) Differential effects of HPV 6, 16 and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci USA 86:563-567.
28. Powell TJ, Chen H, Shenoy N, Gazit A, Chen I, Ben-Bassat H, Hartzstark Z, Chauat M, Shawver L, and Levitzki A (1999) Inhibition of EGF receptor signal transdcuction and psoriatic keratinocyte growth by 4-(3-bromophenylamino)-6,7-dimethoxyquinazoline (SU5271). Br J Dermatol, in press.
29. Rheinwald JG and Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinazing colonies from single cells. Cell 6:331-344.
30. Rheinwald JG and Green H (1988) Epidermal growth factor and the multiplication of cultured human epidermal kertatinocytes. Nature (Lond) 265:76-85.
31. Scheffner M, Munger K, Byrine J and Housley P (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527.
32. Shah KV and Howley PM (1999) Papillomaviruses, in Virology (Fields BN ed), Raven Press, New York.
33. Stopler MC, Straight SW, Tsao G, Schlegel R and McCance DJ (1996) The E5 gene of HPV16 enhances keratinocyte immortalization by full length DNA Virology 223:251-254.
34. Straight SW, Humble PW, Jewers RJ and McCance DJ (1993) The E5 oncoprotein of HPV16 transforms fibroblasts and effects the downregulation of the EGFR in keratinocytes. J Virol 67:4521-4532.
35. Testy TD, White A, Livcuos E, Sage W, Realof H, Briot A and Poulose B (1997) Genomic integrity and the genetics of cancer. Cold Spring Harbor Symp Quant Biol 59:265-267.
36. Werness BA, Levine AJ and Howley PM (1990) Association of HPV 16 and 18 E6 protein with p53. Science (Wash DC) 248:76-79.
37. Woodworth CD, Bronden PE, Doniger J, Pirise I, Bornes W, Lancaster WD and DiPaolo JA (1988) Characterization of normal human exocervical epithelial cells immortalized in-vitro by HPV 16 and 18 DNA. Cancer Res 48:4620-4628.
38. Woodworth CD, McMullin E, Iglesias M and Plowman GD (1995) Interleukin 1a and TNFα stimulate autocrine amphiregulin expression and proliferation of human papilloma-immortalized and carcinoma derived cervical epithelium CELIs. Proc Natl Acad Sci USA 92:2840-2844.
39. Woodworth CD, Wang H, Simpson S, Alvarez-Salas LW and Notorio V (1993) Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines. Cell Growth Differ 4:367-376.
40. Zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
41. Zur Hausen H (1994) Viruses in human cancers. Science (Wash DC) 254:1167-1173.